# Xiling Lab

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/xiling-lab

- Industry: Pharmaceuticals
- Headquarters: Chengdu, China
- Website: www.xilinglab.com
- Total disclosed funding: $23M
- Latest round: Series A (Aug 2, 2021)
- Investors on record: 8

## About

Established in 2016 and based in Chengdu, China. Xiling Lab is a biotechnology company that engages in the R&D, clinical trials, production, and commercialization of generic drugs and innovative drugs. It has two wholly subsidiaries, Chengdu Kelingyuan Medical Technology Co., LTD in Chengdu, and GUIXI PHARMATECH PTY LTD in Australia. Dr. Huang Jin Kun, the company's founder, is one of the main pioneers in the invention and application of the modern ruthenium carbene metathesis catalyst.  Xiling Lab has more than 20 invention patents.

Xiling Lab's products can be divided into innovative drug pipes, imaging agents, catalyst agents, and anti-tumor drugs. Innovative drugs are treated for gastrointestinal diseases, tumors, and ophthalmology diseases. Imaging agents include magnetic resonance (MRI) imaging agents and computed tomography (CT) imaging agents. Catalyst agents include Grubbs series catalyst agents, palladium catalyst agents, and ruthenium catalyst agents. Tumor drugs include Eribulinmesylate raw material drugs, DXD, antibody-drug conjugate (ADC), and intermediate raw material drugs.

## Funding rounds

- Series A, Aug 2, 2021, $14M — Share Capital, E-town Sun Fund, Changjiang Securities, Chengdu Mingxi Biological Technology
- Series A, Oct 20, 2020, $7.5M — Share Capital
- Series A, Mar 16, 2017, $1.3M — Ivystone Capital, Aofei Investment, Yilin Environment
- Angel, Nov 1, 2016, $0.7M — CDHT Hi-Tech Venture

## Investors

- CDHT Hi-Tech Venture (https://capitalatlas.ai/funds/cdht-hi-tech-venture) — Angel
- Ivystone Capital (https://capitalatlas.ai/funds/ivystone-capital) — Series A
- Aofei Investment — Series A
- Yilin Environment — Series A
- Share Capital (https://capitalatlas.ai/funds/share-capital) — Series A
- E-town Sun Fund (https://capitalatlas.ai/funds/e-town-sun-fund) — Series A
- Changjiang Securities — Series A
- Chengdu Mingxi Biological Technology — Series A